Jean Marc Bourez has been appointed CEO of EIT Health on an interim basis until the end of December 2022, when a permanent CEO will be selected. Jean Marc replaces Jan Philipp Beck, who served as EIT Health’s CEO since February 2018, and previously COO since 2016.
Jean Marc will also continue in his duties as Managing Director of the EIT Health France Regional Innovation Hub, a position he has held since 2016. During his time at EIT Health, Jean Marc has led the strategy for EIT Health in France, as well as coordinated a number of strategic initiatives to strengthen the organisation’s ‘access to finance’ offering including the development of the Venture Centre of Excellence and Invest Health (a newly formed commercial entity of EIT Health).
“I am pleased to lead EIT Health during a crucial time for both the organisation, and indeed for European healthcare. Recent events have led to significant change in our sector, and innovation is a crucial ingredient in navigating and triumphing during such evolution. The EIT Health network is incredibly strong, and I am excited to further be part of what our organisation can achieve. I would also like to take this opportunity to extend my sincere thanks to Jan-Philipp Beck, who has taken the organisation from strength-to-strength during its formative years, and who leaves an impressive legacy behind,” said Jean Marc Bourez, CEO ad interim, EIT Health and Managing Director, EIT Health France.
The recruitment process for a permanent CEO will begin immediately, and enquiries can be directed to Natalie Ozel, HR Manager ([email protected]).
This article was first published on 14 March by EIT Health.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
